Xponance, Inc. Mirum Pharmaceuticals, Inc. Call Options Transaction History
Xponance, Inc.
- $12.3 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
269Shares Held
57.5MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$471 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$363 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$224 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$191 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$183 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.55B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...